Business Today
Subscribe
PMS TodayUS NewsIndiaUPSTARTWeatherBT ShortsNRIEducationElection
BT India 100BT GolfBT Mindrush
Search

COMPANIES

No Data Found

NEWS

No Data Found
Advertisement
News
markets
stocks
Chandra Bhagat Pharma Ltd
Chandra Bhagat Pharma Ltd

Chandra Bhagat Pharma Ltd Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 2,000
Jul 01, 2025 Closed
  • BSE
Share
  • Whatsapp
  • Twitter
  • Facebook
₹57.95
₹-0.05 (-0.09%)
57.95Low
Today’s Performance
58.00High
46.15Low
52 Week’s Performance
85.50High

bt_logoStock Performance

  • 1 Day-0.09%
  • 1 Week10.80%
  • 1 Month3.48%
  • 3 Months-3.37%
  • 6 Months-12.20%
  • 1 Year-26.65%
  • 3 Years-18.23%
  • 5 Years3.33%

bt_logoStock Summary

  • Face Value (₹)10.00
  • Beta-0.09
  • 52-Week Low (₹)46.15
  • 52-Week High (₹)85.50
  • Price-to-Book (X)*1.46
  • Dividend Yield (%)-
  • Price-to-Earnings (P/E) (X)*50.83
  • Earnings Per Share (₹)1.14
  • Market Cap (₹ Cr.)*43.72
* Values as of last close price

bt_logoCOMPETITORS

BT TV

Another Fashion Scandal? Prada’s ₹ 1.25 Lakh Shoes Look Exactly Like Indian Juttis2:10Another Fashion Scandal? Prada’s ₹ 1.25 Lakh Shoes Look Exactly Like Indian Juttis
India–UK FTA | NSE’s Ashish Chauhan: Mass-Market Carmakers Remain Unaffected| Auto Sector2:00India–UK FTA | NSE’s Ashish Chauhan: Mass-Market Carmakers Remain Unaffected | Auto Sector
How Shankar Sharma Plays the Market Pitch | Smallcaps vs Largecaps1:36How Shankar Sharma Plays The Market Pitch | Smallcaps Vs Largecaps
UK Deal Signed, But U.S. Trade Deal Much Bigger in Scale and Intent, Says Dr Mukesh Aghi1:32UK Deal Signed, But U.S. Trade Deal Much Bigger in Scale and Intent, Says Dr Mukesh Aghi
Thailand-Cambodia Clash Over Lord Shiva Temple: Preah Vihear Dispute Turns Violent2:33Thailand-Cambodia Clash Over Lord Shiva Temple: Preah Vihear Dispute Turns Violent
Modi Gets Grand Welcome In Maldives: Smiles, Deals & Diplomatic Undercurrents! | $565M Pact Ahead?2:53Modi Gets Grand Welcome In Maldives: Smiles, Deals & Diplomatic Undercurrents! | $565M Pact Ahead?
India–UK FTA | NSE’s Ashish Chauhan: Scotch Tariff Cuts to Unlock Big Gains for Indian Companies2:28India–UK FTA | NSE’s Ashish Chauhan: Scotch Tariff Cuts To Unlock Big Gains For Indian Companies
VP Jagdeep Dhankhar Resigns: How Is The Vice-President Of India Elected?4:00VP Jagdeep Dhankhar Resigns: How Is The Vice-President Of India Elected?
Monday Market Strategy | Key Support Level For Nifty & Nifty Banks | Nifty Monthly Expiry Strategy3:45Monday Market Strategy | Key Support Level For Nifty & Nifty Banks | Nifty Monthly Expiry Strategy
Honda Challenges Hero MotoCorp With Shine 100 Deluxe And CB125 Hornet5:46Honda Challenges Hero MotoCorp With Shine 100 Deluxe And CB125 Hornet
View more

bt_logoFAQ's

What was Chandra Bhagat Pharma Ltd share price previously?
Chandra Bhagat Pharma Ltd share price was down by -0.09% from the previous closing price of ₹58.00.
Who are peers of Chandra Bhagat Pharma Ltd?
The peers of Chandra Bhagat Pharma Ltd are Sun Pharmaceutical Industries Ltd, Divis Laboratories Ltd, Cipla Ltd, Torrent Pharmaceuticals Ltd, Mankind Pharma Ltd, Dr Reddys Laboratories Ltd, Zydus Lifesciences Ltd.
Who is/are the promoter/promoters of Chandra Bhagat Pharma Ltd?
The promotor/promotors of Chandra Bhagat Pharma Ltd are Hemant C Bhagat, Pranav H Bhagat, Prachi Pranav Bhagat, Ravindra Gajanan Awati, Abha Praveen Doshi, Rajni Dawani.
What has been 52-week high of Chandra Bhagat Pharma Ltd stocks?
The highest price of Chandra Bhagat Pharma Ltd stock is ₹85.50 in the last 52-week.
What is the share price of Chandra Bhagat Pharma Ltd (CBPL) today on BSE?
As on Jul 01, 2025 Chandra Bhagat Pharma Ltd (CBPL)’s share price on BSE is Rs 57.95
What is the market cap of Chandra Bhagat Pharma Ltd (CBPL)?
The current market capitalisation of Chandra Bhagat Pharma Ltd (CBPL) is 43.72 crores
What is Chandra Bhagat Pharma Ltd Share symbol?
The symbol of Chandra Bhagat Pharma Ltd is .
What is the PE ratio of Chandra Bhagat Pharma Ltd (CBPL)?
The current PE ratio of Chandra Bhagat Pharma Ltd (CBPL) is 50.83.
What is the PB ratio of Chandra Bhagat Pharma Ltd (CBPL)?
The current PB ratio of Chandra Bhagat Pharma Ltd (CBPL) is 1.46.
Today’s High & Low share prices of Chandra Bhagat Pharma Ltd (CBPL) on BSE?
Today, the share price of Chandra Bhagat Pharma Ltd (CBPL) on BSE touched a high of Rs 58 and a low of Rs 57.95
What price did Chandra Bhagat Pharma Ltd (CBPL) shares open on the BSE today?
On BSE, the share price of Chandra Bhagat Pharma Ltd (CBPL) opened at Rs 58
What is the 52-week high of Chandra Bhagat Pharma Ltd (CBPL)?
The 52-week high price of Chandra Bhagat Pharma Ltd (CBPL) is Rs 85.50
What is the 52-week low of Chandra Bhagat Pharma Ltd (CBPL)?
The 52-week low price of Chandra Bhagat Pharma Ltd (CBPL) is Rs 46.15

bt_logoAbout Chandra Bhagat

Chandra Bhagat Pharma Ltd, incorporated in the year 2003, has its registered office in 323-F Bhagat Bhuvan, Dr Ambedkar Road Matunga (E), Mumbai, Maharashtra, 400019, 91-22-24146154. The main industry in which Chandra Bhagat Pharma Ltd operates is Pharmaceuticals - Indian - Bulk Drugs & Formln.

Auditor/Auditors for Chandra Bhagat Pharma Ltd is/are A Y & Co. In the main management, Hemant C Bhagat is chairman and Rajni Dawani is the company secretary for Chandra Bhagat Pharma Ltd.

  • HCB
    Hemant C BhagatChairman & Managing Director
  • PHB
    Pranav H BhagatWhole-time Director
  • PPB
    Prachi Pranav BhagatDirector & CFO
  • RGA
    Ravindra Gajanan AwatiIndependent Director
  • APD
    Abha Praveen DoshiIndependent Director
  • RD
    Rajni DawaniCompany Sec. & Compli. Officer

bt_logoTop Stories

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.